Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tivantinib plus Cetuximab in MET-high Metastatic Colorectal Cancer
NCT01892527Phase 2Completed
- Sponsor
- Armando Santoro
- Start
- Mar 2013
- Primary completion
- May 2016
- Countries
- 1
01
Overview
A Phase 2 trial of tivantinib in colorectal cancer (CRC), sponsored by Armando Santoro. Started Mar 2013; status: completed.
02
Drugs
tivantinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01892527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01892527.